[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100364856":3},{"organization":4,"armGroups":7,"interventions":15,"overallOfficials":27,"centralContacts":34,"locations":43,"responsibleParty":81,"collaborators":21,"id":83,"slug":21,"hasResults":84,"nctId":85,"briefTitle":86,"officialTitle":87,"acronym":88,"eligibilityCriteria":89,"healthyVolunteers":84,"sex":90,"minAge":91,"maxAge":21,"enrollmentInfo":92,"targetDuration":21,"studyType":95,"phases":96,"briefSummary":98,"conditions":99,"keywords":101,"overallStatus":46,"whyStopped":21,"lastUpdateSubmitDate":108,"lastUpdatePostDateStruct":109,"startDateStruct":112,"completionDateStruct":114,"leadSponsor":116,"locationsCount":117},{"fullName":5,"class":6},"Centre Hospitalier Universitaire de Saint Etienne","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"QuantiFERON Test","EXPERIMENTAL","Patient with CytoMegaloVirus (CMV) infection will be included. They will have biopsies and blood samples, composite of QuantiFERON-CytoMegaloVirus (QF-CMV) assay.",[13,14],"Procedure: Biopsies","Biological: Blood samples",[16,22],{"type":17,"name":18,"description":19,"armGroupLabels":20,"otherNames":21},"PROCEDURE","Biopsies","Two more biopsies in inflammatory zone will be collected.",[9],null,{"type":23,"name":24,"description":25,"armGroupLabels":26,"otherNames":21},"BIOLOGICAL","Blood samples","Blood samples will be performed necessary at QuantiFERON-CMV (QF-CMV) test.",[9],[28,31],{"name":29,"affiliation":5,"role":30},"Xavier ROBLIN, MD PhD","PRINCIPAL_INVESTIGATOR",{"name":32,"affiliation":5,"role":33},"Sylvie PILLET, PhD","STUDY_DIRECTOR",[35,40],{"name":29,"role":36,"phone":37,"phoneExt":38,"email":39},"CONTACT","(0)477828119","+33","xavier.roblin@chu-st-etienne.fr",{"name":32,"role":36,"phone":41,"phoneExt":38,"email":42},"(0)477828315","sylvie.pillet@chu-st-etienne.fr",[44,67],{"facility":45,"status":46,"city":47,"state":21,"zip":21,"country":48,"cosmosGeoPoint":49,"geoPoint":54,"contacts":55},"HCL-Hôpital Lyon Sud","RECRUITING","Lyon","France",{"type":50,"coordinates":51},"Point",[52,53],4.84789,45.74906,{"lat":53,"lon":52},[56,58,61,63,65],{"name":57,"role":30,"phone":21,"phoneExt":21,"email":21},"Stéphane NANCEY, MD PhD",{"name":59,"role":60,"phone":21,"phoneExt":21,"email":21},"Gilles BOSCHETTI, MD PhD","SUB_INVESTIGATOR",{"name":62,"role":60,"phone":21,"phoneExt":21,"email":21},"Claire GAY, MD",{"name":64,"role":60,"phone":21,"phoneExt":21,"email":21},"Bernard FLOURIE, MD",{"name":66,"role":60,"phone":21,"phoneExt":21,"email":21},"Pauline DANION, MD",{"facility":68,"status":46,"city":69,"state":21,"zip":21,"country":48,"cosmosGeoPoint":70,"geoPoint":74,"contacts":75},"Chu Saint-Etienne","Saint-Etienne",{"type":50,"coordinates":71},[72,73],4.39,45.43389,{"lat":73,"lon":72},[76,77,79],{"name":29,"role":30,"phone":21,"phoneExt":21,"email":21},{"name":78,"role":60,"phone":21,"phoneExt":21,"email":21},"Pauline VEYRARD, MD",{"name":80,"role":60,"phone":21,"phoneExt":21,"email":21},"Emilie DEL TEDESCO, MD",{"type":82,"investigatorFullName":21,"investigatorTitle":21,"investigatorAffiliation":21,"oldNameTitle":21,"oldOrganization":21},"SPONSOR","100364856",false,"NCT04030676","QuantiFERON-CMV Test in a Prediction for Colic Cytomegalovirus Reactivation During Ulcerative Colitis","Place of the QuantiFERON-CMV (QF-CMV) Test in a Prediction for Colic Cytomegalovirus Reactivation During Ulcerative Colitis (UC)","RECOHFERRON","Inclusion Criteria:\n\n* Patient with seropositive for CytoMegaloVirus (CMV) (IgG+)\n* Patient requiring hospitalization for flare of Ulcerative Colitis (UC) with Mayo score \\> 5 and an endoscopic subscore ≥ 2\n* Social security affiliation\n* Signed informed consent\n\nExclusion Criteria:\n\n* Wardship patient and curatorial patient\n* Patient unable to understand or sign the protocol\n* Colectomy total or partial","ALL","18 Years",{"count":93,"type":94},196,"ESTIMATED","INTERVENTIONAL",[97],"NA","CytoMegaloVirus (CMV) infection impairs evolution of Ulcerative Colitis (UC) leading to more severe and resistant to immunosuppressive therapies flare-up. CytoMegaloVirus (CMV) reactivation is assessed by the quantification of the CytoMegaloVirus (CMV) DeoxyriboNucleic Acid (DNA) load by real-time PCR (qPCR) in colonic biopsies; this assay is invasive and costly. The QuantiFERON-CytoMegaloVirus (QF-CMV) assay measures the immune response against CytoMegaloVirus (CMV) in a blood specimen.",[100],"Cytomegalovirus Infections",[102,103,104,105,106,107],"Immune response against","QuantiFERON-CytoMegaloVirus (QF-CMV)","Ulcerative Colitis (UC)","CytoMegaloVirus (CMV)","quantitative PolymeraseChainReaction (qPCR)","ImmunoHistoChemistry (IHC)","2025-04-28",{"date":110,"type":111},"2025-04-29","ACTUAL",{"date":113,"type":111},"2019-07-17",{"date":115,"type":94},"2026-04",{"name":5,"class":6},2]